Outlook Therapeutics Inc
NASDAQ:OTLK
Other Pre-Announcement
Outlook Therapeutics Reports Financial Results For FY2020
Published: 12/23/2020 14:15 GMT
Outlook Therapeutics Inc (OTLK) - Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update.
Outlook Therapeutics - Pivotal Data Expected in Mid-2021 From Phase 3 Registration Trial for Ons-5010 With New Bla Filing Expected in H2 2021.
Outlook Therapeutics - Pivotal Data Expected in Mid-2021 From Phase 3 Registration Trial for Ons-5010 With New Bla Filing Expected in H2 2021.